site map  

Coagulation Factor Xa

  PRODUCTS ORDERING SERVICES ABOUT US FAQ/TECH NOTES CONTACT

Human Proteins   Bovine Proteins   Mouse Proteins   Other Species  Inhibitors

   Substrates   Antibodies   Sample Collection Tubes  Assay Kits  Deficient Plasmas  Pricing

 

 

 


Haematologic Technologies, Inc.

57 River Road

Essex Junction, VT USA

Tel: 802.878.1777

Fax: 802.878.1776

Email: hti@haemtech.com

HOME PAGE

PARTICIPATION OF FACTOR Xa IN PROTHROMBINASE The participation of the serine protease factor Xa in the prothrombinase complex is illustrated. Membrane bound factor Xa binds to membrane bound factor Va to form the prothrombinase complex. This complex effectively converts the zymogen prothrombin (II) to the active serine protease thrombin (IIa) by proteolytic removal of the fragment 1.2 (F1.2) portion of prothrombin.

Activation of the zymogen, factor X, by either the intrinsic or extrinsic factor Xase complexes produces the active serine protease factor Xa (1,2). The activation of factor X requires proteolytic cleavage of the heavy chain, resulting in the release of an activation glycopeptide. The heavy chain region in factor Xa contains the serine protease catalytic domain, while the light chain, as in the zymogen, contains the membrane binding domain.

 
Factor Xa participates in the prothrombinase complex, which catalyzes the rapid conversion of prothrombin to thrombin. Prothrombinase is an enzyme complex composed of factor Xa (enzyme) and factor Va (cofactor) assembled on a cellular surface in the presence of calcium ions. Although factor Xa can independently catalyze the activation of prothrombin, the rate at which this reaction occurs is increased nearly 300,000-fold with complete assembly of the prothrombinase complex. The clotting activity of factor Xa in vivo is terminated by either inactivation of the cofactor, factor Va, or by direct inhibition of factor Xa by inhibitors, such as ATIII, after disassembly of the prothrombinase complex. 

In recent years, molecular biologists have utilized factor Xa for site specific cleavage of fusion proteins expressed in bacteria (9-12). A factor Xa-sensitive site is incorporated between the recombinant protein of interest and peptides or proteins which facilitate purification and/or expression. The target protein is released from the expressed hybrid by cleavage with factor Xa. The factor Xa can then be easily removed by affinity chromatography. 

Factor Xa is prepared by activating purified factor X with the factor X activator isolated from Russell's viper venom. Factor Xa is purified from the activation mixture by chromatography over benzamidine-Sepharose followed by gel filtration (1,3). Several modified forms of factor Xa are also available including: A) active-site blocked factor Xa containing either the tripeptide chloromethyl ketone inhibitor EGRck, or the fluorescent inhibitor Dansyl-EGRck; and B) human Gla-domainless β-factor Xa. The enzyme is supplied in 50% (vol/vol) glycerol/H2O and should be stored at -20°C. Purity is determined by SDS-PAGE analysis and activity is measured in a factor Xa clotting assay and/or chromogenic substrate assay. 

Properties of Factor Xa

Localization: Plasma
Mode of action: Enzyme component of the prothrombinase complex
Molecular weight: 46,000 (human) (4)
45,300 (bovine) (5)
Extinction coefficient:
E
1 %
1 c m, 280 nm
= 11.6 (human) (6)
= 12.4 (bovine) (7)
Specific activity: approximately 1000 units/mg
Structure: two subunits, Mr=16,200 and 29,000 (human) (6), Mr=16,500 and 28,800 (bovine) (5), NH2-terminal gla domain, two EGF domains
Percent carbohydrate: 3.0 % (human) (8)
2.1 % (bovine) (8)
Post-translational modifications: eleven gla residues,
one
β-hydroxyaspartate

Catalog Number

Description

HCXA-0060

Human Factor Xa  (Compliment fluorogenic substrate(s): HTI Catalog # SN-7)

HCBXA-0061

Human β-Factor Xa

HCXA-GD

Human Gla-Domainless β-Factor Xa

HCXA-EGR

Human Factor Xa -EGR

HCXA-DEGR

Human Factor Xa - DEGR

HCXA-BEGR

Human Factor Xa - BEGR (Biotinylated EGR)

BCXA-1060

Bovine Factor Xa

BCXA-EGR

Bovine Factor Xa - EGR

BCXA-DEGR

Bovine Factor Xa - DEGR

MCXA-5060

Mouse Factor Xa

DOWNLOAD FACTOR XA APPLICATION PDF

PRICING

INQUIRE ABOUT THIS PRODUCT

References 

1. Jesty, J., et al., Methods Enzymol., 45, 95 (1976). 
2. Jackson, C.M., Ann. Rev. Biochem., 49, 765 (1980). 
3. Krishnaswamy, S., et al., J.Biol. Chem., 262, 3291 (1987). 
4. Discipio, R.G., et al., Biochemistry, 16, 5253 (1977). 
5. Fujikawa, K. and Davie, E.W., Methods Enzymol., 45, 89 (1976). 
6. Krishnaswamy, S., et al., J. Biol. Chem., 261, 8997 (1986). 
7. Discipio, R.G., et al., Biochemistry, 16, 698 (1977). 
8. Jackson, C.M., et al., Biochemistry, 7, 4506 (1968). 
9. Fujikawa, K., Biochemistry, 13, 5290 (1974).
10. Nagai, K., et al., Proc. Natl. Acad. Sci. USA, 82, 7252 (1985). 
11. Aurell, L., et al., Thromb. Res., 11, 595 (1984). 
12. Nagai, K. and Thogersen, H., Nature, 309, 810 (1984).

 Please inquire about products not listed.  We can also custom purify proteins from other species. 

© 2004 Haematologic Technologies, Inc. All Rights Reserved